X

Drug Profile

Calcipotriol/hydrocortisone

Alternative Names: LEO-80190

Latest Information Update: 02 Oct 2021

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator LEO Pharma
Class Anti-inflammatories; Antipsoriatics; Dihydroxycholecalciferols; Glucocorticoids; Pregnenediones; Small molecules; Vitamin D analogues
Mechanism of Action Calcitriol receptor agonists; Glucocorticoid receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Psoriasis

Most Recent Events

23 Sep 2009 LEO 80190 is no longer licensed to Warner Chilcott
15 Sep 2005 Warner Chilcott has licensed the full portfolio of LEO Pharma's present and future psoriasis therapies in USA
26 May 2005 Phase-II clinical trials in Psoriasis in Denmark (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com